Trial NCT03518320

View at ClinicalTrials.gov 
Org. Study IDs: TAR-200-104

Last trial update was posted on 2020-07-14

MeSH Interventions

Gemcitabine Nivolumab

MeSH Conditions

Urinary Bladder Neoplasms

Other Conditions

Bladder Cancer TNM Staging Distant Metastasis (M) M0 Bladder Cancer TNM Staging Primary Tumor (T) T2 Bladder Cancer TNM Staging Primary Tumor (T) T2A Bladder Cancer TNM Staging Primary Tumor (T) T2B Bladder Cancer TNM Staging Primary Tumor (T) T3 Bladder Cancer TNM Staging Primary Tumor (T) T3A Bladder Cancer TNM Staging Primary Tumor (T) T3B Bladder Cancer TNM Staging Regional Lymph Node (N) N0 Bladder Cancer TNM Staging Regional Lymph Node (N) N1

Stopping Reasons

Business objectives have changed

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID